We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.75B
AUM Growth
+$282M
Cap. Flow
+$98.4M
Cap. Flow %
3.57%
Top 10 Hldgs %
25.32%
Holding
537
New
191
Increased
80
Reduced
82
Closed
170

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$44.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$42.1M
3
SPLK
Splunk Inc
SPLK
+$32.5M
4
MSFT icon
Microsoft
MSFT
+$29.8M
5
ABBV icon
AbbVie
ABBV
+$29.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$61.8M
2
TJX icon
TJX Companies
TJX
+$44.7M
3
UBER icon
Uber
UBER
+$43.5M
4
STZ icon
Constellation Brands
STZ
+$38M
5
PYPL icon
PayPal
PYPL
+$34.2M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 12.59%
3 Industrials 10.36%
4 Healthcare 6.17%
5 Communication Services 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVA
526
DELISTED
NuVasive, Inc.
NUVA
– –
-164,329
Closed -$6.79M
GOGN
527
DELISTED
GoGreen Investments Corporation
GOGN
– –
-302,249
Closed -$3.23M
BLU
528
DELISTED
BELLUS Health Inc.
BLU
– –
-54,000
Closed -$389K
RXDX
529
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-27,000
Closed -$2.9M
RXDX
530
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-20,301
Closed -$2.18M
MEKA
531
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
– –
-300,000
Closed -$3.06M
PNTM
532
CALL
DELISTED
Pontem Corporation
PNTM
– –
-110,332
Closed -$18.5K
PSPC
533
CALL
DELISTED
Post Holdings Partnering Corporation
PSPC
– –
-119,441
Closed -$16.1K
PSPC
534
DELISTED
Post Holdings Partnering Corporation
PSPC
– –
-358,323
Closed -$3.63M
TCVA
535
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
– –
-321,957
Closed -$3.3M
CTIC
536
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-970,584
Closed -$4.08M
CTIC
537
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
– –
-120,800
Closed -$507K
18 19 20 21
22

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q2 2023 Portfolio in Review

As of Q2 2023, J. Goldman & Co held 537 positions worth $2.75B, up 11% from $2.47B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

J. Goldman & Co deployed $98.4M of net new capital in Q2 2023, opening 191 new positions and adding to 80 existing holdings. Its largest new stake was Splunk Inc: 342,083 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Uber, an estimated $43.5M trimmed.

  • J. Goldman & Co's largest Q2 2023 buy was Splunk Inc: 342,083 shares worth $36.3M.
  • J. Goldman & Co added most to iShares Russell 2000 ETF in Q2 2023, an estimated $44.3M increase.
  • J. Goldman & Co's biggest Q2 2023 reduction was Uber, cutting an estimated $43.5M.
  • J. Goldman & Co fully exited Meta Platforms (Facebook) in Q2 2023, selling an estimated $61.8M.
  • J. Goldman & Co's ten largest holdings make up 25% of its $2.75B portfolio in Q2 2023.
  • J. Goldman & Co opened 191 new positions and closed 170 in Q2 2023.
  • J. Goldman & Co's portfolio value rose 11% quarter-over-quarter to $2.75B.

Based on J. Goldman & Co's 13F filing for Q2 2023, filed 14 Aug 2023.